Generation Development Group (ASX:GDG) Releases March Quarterly Update
Generation Development Group (ASX:GDG) reports robust March quarter growth, solidifying market leadership and achieving ASX 200 status.
Lumos Diagnostics (ASX:LDX) Secures Additional Medicare Coverage
Lumos Diagnostics (ASX:LDX) expands Medicare reimbursement for FebriDx to over 55% of US coverage, enhancing market access.
Hydrocarbon Dynamics Limited (ASX:HCD) Releases March 2025 Quarterly Report
Hydrocarbon Dynamics Limited (ASX:HCD) reports repeat orders, ongoing trials, and financial updates in its March 2025 quarterly activities report.
Global Masters Fund Limited (ASX:GFL) Releases Quarterly Convertible Notes Report
Global Masters Fund Limited (ASX:GFL) reports stable conversion price and a 13.54% LTV ratio in its quarterly Convertible Notes report.
Insignia Financial Ltd (ASX:IFL) Announces Q3 2025 Business Update
Insignia Financial Ltd (ASX:IFL) reports a 1.5% decline in FUMA for Q3 2025, while progressing strategic initiatives and achieving strong inflows in key channels.
Cettire Limited (ASX:CTT) Announces Q3 FY25 Trading Update
Cettire Limited (ASX:CTT) announces Q3 FY25 trading results, highlighting revenue growth, customer increase, and cost-cutting measures.
Paladin Energy Ltd (ASX:PDN) Announces Quarterly Cash Flow Report
Paladin Energy Ltd (ASX:PDN) releases its quarterly cash flow report, highlighting operations, investments, and financing activities.
Telix Pharmaceuticals Limited (ASX:TLX) Reports $186M Q1 Revenue
Telix Pharmaceuticals Limited (ASX:TLX) reports a 62% increase in Q1 2025 revenue, reaching $186M.
Australasian Metals Limited (ASX:A8G) Announces Portfolio Rationalisation and Exploration Progress
Australasian Metals Limited (ASX:A8G) announces strategic portfolio rationalisation and exploration progress across multiple projects.
Tower (ASX:TWR) Updates FY25 Guidance
Tower (ASX:TWR) revises FY25 underlying NPAT upwards to $70m-$80m amid improved claims performance and strategic investments.